Respiratory Muscle Assesment in COVID-patients Without Hospitalization

Launched by RWTH AACHEN UNIVERSITY · Oct 26, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how well the breathing muscles function in people who had COVID-19 but did not need to be hospitalized. Some individuals who recover from COVID-19 continue to experience symptoms such as fatigue and trouble breathing during physical activities. The goal of the study is to measure the strength and performance of their respiratory muscles to better understand these ongoing issues.

To participate, individuals must be at least 18 years old, have had a COVID-19 infection without being hospitalized, and be able to give consent. The study will not include people with certain heart or lung diseases, a high body mass index, or other specific medical conditions that might affect their ability to take part. If eligible, participants will have their respiratory muscle function tested in a lab setting. This research is important to help improve the understanding of post-COVID symptoms and develop better support for those affected.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with COVID-19 infection without hospitalization during the acute infection (n=25)
• • Patients aged at least 18 years, who are mentally and physically able to consent and participate into the study
• Exclusion Criteria:
• • Clinically pre-established cardiovascular disease or other pulmonary diseases which might lead to exertional dyspnea (systolic heart failure, COPD).
• • Body-mass-index (BMI) \>40
• • Expected absence of active participation of the patient in study-related measurements
• • Alcohol or drug abuse
• • Metal implant in the body that is not MRI compatible (NON MRI compatible pacemaker, implantable defibrillator, cervical implants, e.g. brain pacemakers etc.)
• • Slipped disc
• • Epilepsy
• • Bound to a wheel chair